- Report
- November 2025
- 60 Pages
United States
From €2319EUR$2,550USD£1,993GBP
- Report
- November 2025
- 110 Pages
North America
From €2955EUR$3,250USD£2,541GBP
- Report
- November 2025
- 140 Pages
Europe
From €2955EUR$3,250USD£2,541GBP
- Report
- September 2026
United States
From €3628EUR$3,990USD£3,119GBP
- Report
- September 2026
Middle East
From €3628EUR$3,990USD£3,119GBP
- Report
- September 2026
Asia Pacific
From €3628EUR$3,990USD£3,119GBP
- Report
- September 2026
Europe
From €3628EUR$3,990USD£3,119GBP
- Report
- February 2026
- 150 Pages
United States
From €4410EUR$4,850USD£3,792GBP
- Report
- September 2026
- 67 Pages
United States
From €1228EUR$1,350USD£1,055GBP
- Report
- September 2026
- 150 Pages
Europe
From €1728EUR$1,900USD£1,485GBP
- Report
- March 2026
- 110 Pages
United States
From €4410EUR$4,850USD£3,792GBP
- Report
- March 2026
- 80 Pages
Middle East, Africa
From €3137EUR$3,450USD£2,697GBP
- Report
- March 2026
- 88 Pages
North America
From €3137EUR$3,450USD£2,697GBP
- Report
- March 2026
- 107 Pages
Asia Pacific
From €3592EUR$3,950USD£3,088GBP
- Report
- March 2026
- 104 Pages
Europe
From €3592EUR$3,950USD£3,088GBP
- Report
- February 2026
- 109 Pages
North America
From €5451EUR$5,995USD£4,687GBP
- Report
- February 2026
- 117 Pages
Europe
From €5451EUR$5,995USD£4,687GBP
- Report
- February 2026
- 117 Pages
Asia Pacific
From €5451EUR$5,995USD£4,687GBP
- Report
- February 2026
- 76 Pages
Middle East, Africa
From €3137EUR$3,450USD£2,697GBP
- Report
- February 2026
- 84 Pages
North America
From €3137EUR$3,450USD£2,697GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more